Towerpoint Wealth’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
Towerpoint Wealth's LLY Position: Q2 2026 in Review
Towerpoint Wealth increased its Eli Lilly (LLY) stake by 6.2% in Q2 2026, buying an estimated $273K and bringing the position to 4,549 shares worth $5.46M. The position accounts for 1.89% of the portfolio, ranked #12.
Towerpoint Wealth first reported a position in LLY in Q1 2019 and has held it in 30 quarters since. 1,803 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Towerpoint Wealth held 4,549 shares of Eli Lilly worth $5.46M as of Q2 2026.
- Towerpoint Wealth bought 267 Eli Lilly shares in Q2 2026, an estimated $273K.
- Eli Lilly made up 1.89% of Towerpoint Wealth's portfolio in Q2 2026, its #12 holding.
- Towerpoint Wealth first reported a position in Eli Lilly in Q1 2019 and has held it in 30 quarters since.
- 1,803 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Towerpoint Wealth's 13F filing for Q2 2026, filed 9 Jul 2026.